Biotech ETFs Will Enjoy a More Favorable Environment

Now that the political overhang on the markets has more or less abated, biotechnology stocks and sector-related exchange traded funds could enjoy more favorable conditions under a Donald Trump presidency. On the recent webcast (available on-demand for CE Credit), Will Trump Make Biotechnology Great Again?, Paul Yook, Founder of LifeSci Index Partners, and Co-Portfolio Manager…Click to read more at